Diasome Pharmaceuticals Announces First Closing of Series C Financing Round
Diasome Secures Series C Funding with Eli Lilly Participation CLEVELAND, OH, USA, December 7, 2023 /EINPresswire.com/ -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company that leverages a novel hepatocyte cell targeting …